+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Tavaborole"

Onychomycosis Treatment Market - Global Forecast 2026-2032 - Product Thumbnail Image

Onychomycosis Treatment Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 187 Pages
  • Global
From
Onychomycosis Market Report and Forecast 2025-2034 - Product Thumbnail Image

Onychomycosis Market Report and Forecast 2025-2034

  • Report
  • July 2025
  • 350 Pages
  • Global
From
From
  • 5 Results (Page 1 of 1)
Loading Indicator

Tavaborole is a topical antifungal drug used to treat fungal infections of the skin, such as athlete's foot, jock itch, and ringworm. It is a member of the boron-containing antifungal class of drugs, and is available in both prescription and over-the-counter forms. Tavaborole is used to treat a variety of fungal infections, including those caused by Candida, Trichophyton, and Epidermophyton species. It is also used to treat onychomycosis, a fungal infection of the nails. Tavaborole is an important drug in the treatment of infectious diseases, as it is effective against a wide range of fungal infections. It is generally well-tolerated, with few side effects. It is also relatively inexpensive, making it an attractive option for those who cannot afford more expensive treatments. The Tavaborole market is highly competitive, with a number of companies offering products containing the drug. These include Bayer, Novartis, Merck, Pfizer, and GlaxoSmithKline. Show Less Read more